Binfeng Lu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Top Venues

Nature communications

Future oncology (London, England)

Science advances

Nature nanotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Future oncology (London, England) 20 (17) (2024)
Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Future oncology (London, England) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Future oncology (London, England) 20 (17) (2024)
Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Future oncology (London, England) 20 (17) (2024)
Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Future oncology (London, England) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Future oncology (London, England) (2024)
Runzi Sun, Hongyu Zhao, David Shihong Gao, Andrew Ni, Haochen Li, Lujia Chen, Xinghua Lu, Kong Chen, Binfeng Lu
Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Science advances 9 (34) (2023)
Yifei Wang, Yueshan Zhao, Weiwei Guo, Ghanshyam Singh Yadav, Chetana Bhaskarla, Zehua Wang, Xiaofei Wang, Sihan Li, Yue Wang, Yuang Chen, Dhamotharan Pattarayan, Wen Xie, Song Li, Binfeng Lu, Udai S Kammula, Min Zhang, Da Yang
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Science advances 8 (49) (2022)
Yuang Chen, Yixian Huang, Qinzhe Li, Zhangyi Luo, Ziqian Zhang, Haozhe Huang, Jingjing Sun, LinXinTian Zhang, Runzi Sun, Daniel J Bain, James F Conway, Binfeng Lu, Song Li
Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy. Nature nanotechnology (2022)
Zhuoya Wan, Runzi Sun, Yang-Wuyue Liu, Sihan Li, Jingjing Sun, Jiang Li, Junjie Zhu, Pearl Moharil, Bei Zhang, Pengfei Ren, Guolian Ren, Min Zhang, Xiaochao Ma, Shuangshuang Dai, Da Yang, Binfeng Lu, Song Li
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science advances 7 (50) (2021)